Mechanism of Action
Spacer acquisition during adaptation, the process of acquiring new immune memories by CRISPR systems, requires Cas1 and Cas2 proteins; the nuclease activity of Cas1, but not that of Cas2, is essential. In addition, involvement of Cas3, Cas4, and the effector complex in adaptation has been demonstrated for type I systems (Mohanraju et al., 2016) . For some of the III-B systems, acquisition of spacers originating from RNA and the role of reverse transcriptase fused to Cas1 protein in this process have been demonstrated (Silas et al., 2016) . Pre-crRNA is usually processed by the dedicated ribonuclease Cas6, which cleaves the repeat to produce a CRISPR (cr)RNA with a 5′ handle, spacer, and 3′ stem-loop structure. In I-C systems, this function is performed by Cas5, which is both a ribonuclease and an effector complex subunit (Mohanraju et al., 2016) . The same crRNAs can be shared by different type I or type III complexes that are present in the same cell. The Cas7 proteins function as a "ruler," binding the spacer region to form a chain with a varying number of monomers depending on the length of the spacer (Mohanraju et al., 2016) . The dedicated interference helicase-nuclease Cas3 is recruited by the type I effector complexes upon recognition of the PAM and a cognate protospacer and R-loop formation. The HD domain is responsible for DNA cleavage. Type III systems lack Cas3 and do not recognize a PAM. In these systems, DNA cleavage requires the activities of both the HD domain and the cyclase domain of Cas10, the large subunit of the effector complex (Mohanraju et al., 2016) . Type III systems can also target ssRNA through the Cas7 family proteins, such as Csm3 in subtype III-A and Cmr4 in subtype III-B. The RNA and DNA degradation reactions in these systems are coupled, ensuring targeting of actively transcribed phage DNA (Kazlauskiene et al., 2016) .
Effector Complex Architecture
Despite extremely low or undetectable sequence similarity, type I and III systems share common principles of effector complex organization (Makarova et al., 2011) . Several cryo-electron microscopy structures for both type I and III systems effector complexes show remarkable similarity of the overall architecture and shape. Most of the subunits belong to the RAMP (repeat associated mysterious proteins) family that consists of three distinct groups (Cas5, Cas6, and Cas7). Typically, Cas6 and Cas5 proteins contain two RRM (RNA recognition motif) domains, whereas Cas7 is a single-RRM protein. Effector complexes contain one Cas5 subunit and several Cas7 subunits. The Cas5 subunit binds the 5′ handle of the crRNA and interacts with the large subunit of the effector complex (Cas8 in type I and Cas10 in type III), forming a stable, two-subunit subcomplex. The small subunit is typically present in several copies and interacts with the crRNA backbone bound to Cas7 (Mohanraju et al., 2016) .
Regulatory and Other Ancillary Functions
Several groups of Cas proteins that are common in Class 1 systems so far have not been linked to a specific function. In particular, protein containing the CARF domain that is predicted to bind nucleotide ligands and is typically fused to a DNA-binding domain and different nuclease domains is implicated in the regulation of the CRISPR-Cas function, including sensing genotoxic stress and possibly coupling adaptive immune response to programmed cell death (Makarova et al., 2014) .
Origin and Evolution
The Class 1 effector complexes center around the RRM domains that are present in Cas10 and all three families of RAMPs. Considering also the homology between the C-terminal domain of the large subunit (Cas8 and Cas10 in types I and III, respectively) and the small subunit of the effector complexes, these complexes might have evolved from a single Cas10-like protein containing an RRM domain with nuclease activity (Shmakov et al., 2015) . Thus, the ancestral class 1 systems could have most closely resembled modern type III. Cas1 and CRISPR repeats probably originated from transposable elements, known as Casposons, that utilize Cas1 homologs as integrases (Koonin and Krupovic, 2015) . Loss of the catalytic activity of the large subunit and recruitment of Cas3 for DNA cleavage were the key events in the evolution of type I systems. Further degradation of the large subunit and loss of the adaptation module (Cas1 and Cas2) yielded type IV systems.
Anti-CRISPR Proteins and Bacteriophage-Encoded CRISPR-Cas Systems
At least some bacteriophages encode multiple anti-CRISPR proteins (Pawluk et al., 2016) . Although such proteins have been experimentally studied only in Pseudomonas phages and shown to inhibit I-F systems, it can be predicted that other viruses and integrated elements encode numerous currently uncharacterized proteins that act against most of CRISPR-Cas systems. Conversely, some bacteriophages have been shown to encode type I CRISPR-Cas systems that target host defense genes (Mohanraju et al., 2016) .
